1. Brindley PJ, Bachini M, Ilyas SI, Khan
SA, Loukas A, Sirica AE, Teh BT, Wongkham S, Gores GJ. Cholangiocarcinoma. Nat
Rev Dis Primers. 2021 Sep 09;7(1):65. [PMC free article] [PubMed]
2.
Krawczyk M, Ziarkiewicz-Wróblewska B,
Podgórska J, Grzybowski J, Gierej B, Krawczyk P, Grąt M, Kornasiewicz O,
Skalski M, Wróblewski T. Intraductal papillary neoplasm of the bile duct - A
comprehensive review. Adv Med Sci. 2021 Mar;66(1):138-147. [PubMed]
3.
Tyson GL, El-Serag HB. Risk factors for
cholangiocarcinoma. Hepatology. 2011 Jul;54(1):173-84. [PMC free article]
[PubMed]
4.
Khan AS, Dageforde LA. Cholangiocarcinoma.
Surg Clin North Am. 2019 Apr;99(2):315-335. [PubMed]
5.
Massarweh NN, El-Serag HB. Epidemiology of
Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control.
2017 Jul-Sep;24(3):1073274817729245. [PMC free article] [PubMed]
6.
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030:
the unexpected burden of thyroid, liver, and pancreas cancers in the United
States. Cancer Res. 2014 Jun 01;74(11):2913-21. [PubMed]
7.
Hezel AF, Deshpande V, Zhu AX. Genetics of
biliary tract cancers and emerging targeted therapies. J Clin Oncol. 2010 Jul
20;28(21):3531-40. [PMC free article] [PubMed]
8.
Uson Junior PLS, Borad MJ. Precision
approaches for cholangiocarcinoma: progress in clinical trials and beyond.
Expert OpinInvestig Drugs. 2022 Jan;31(1):125-131. [PubMed]
9.
Yamada T, Nakanishi Y, Hayashi H,
Tanishima S, Mori R, Fujii K, Okamura K, Tsuchikawa T, Nakamura T, Noji T,
Asano T, Matsui A, Tanaka K, Watanabe Y, Kurashima Y, Ebihara Y, Murakami S,
Shichinohe T, Mitsuhashi T, Hirano S. Targeted amplicon sequencing for primary
tumors and matched lymph node metastases in patients with extrahepatic
cholangiocarcinoma. HPB (Oxford). 2022 Jul;24(7):1035-1043. [PubMed]
10.
Ahmad S, Badr B, Khan A, Rehman R, Ghias K,
Muhammad JS, Khan MR. The Role of K-Ras and P53 in Biliary Tract Carcinoma. J
Pak Med Assoc. 2021 Oct;71(10):2378-2384. [PubMed]
11.
11.Lim JH. Cholangiocarcinoma: morphologic
classification according to growth pattern and imaging findings. AJR Am J
Roentgenol. 2003 Sep;181(3):819-27. [PubMed]
12.
12.Sarcognato S, Sacchi D, Fassan M,
Fabris L, Cadamuro M, Zanus G, Cataldo I, Capelli P, Baciorri F, Cacciatore M,
Guido M. Cholangiocarcinoma. Pathologica. 2021 Jun;113(3):158-169. [PMC free
article] [PubMed]
13.
13.Chen Y, Liu X, Huang L, Chen L, Wang B.
Clinicopathological, etiological and molecular characteristics of intrahepatic
cholangiocarcinoma subtypes classified by mucin production and
immunohistochemical features. Expert Rev Mol Diagn. 2023 May;23(5):445-456. [PubMed]
14.
14.Chung T, Park YN. Up-to-Date Pathologic
Classification and Molecular Characteristics of Intrahepatic
Cholangiocarcinoma. Front Med (Lausanne). 2022;9:857140. [PMC free article]
[PubMed]
15.
15.Banales JM, Marin JJG, Lamarca A,
Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi
C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro
D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C,
Invernizzi P, Mertens JC, Moncsek A, Ilyas SI, Heimbach J, Koerkamp BG, Bruix
J, Forner A, Bridgewater J, Valle JW, Gores GJ. Cholangiocarcinoma 2020: the
next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020
Sep;17(9):557-588. [PMC free article] [PubMed]
16.
Guedj N. Pathology of Cholangiocarcinomas.
Curr Oncol. 2022 Dec 26;30(1):370-380. [PMC free article] [PubMed]
17.
Blechacz B, Komuta M, Roskams T, Gores GJ.
Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol
Hepatol. 2011 Aug 02;8(9):512-22. [PMC free article] [PubMed]
18.
Carson SW, Craven KE, Nauen D, Montemayor
K, Yarchoan M, Burns WR, Merlo CA, West NE. Rapidly progressive metastatic
cholangiocarcinoma in a postpartum patient with cystic fibrosis: a case report.
BMC Pulm Med. 2020 Nov 16;20(1):298. [PMC free article] [PubMed]
19.
Pelsang RE, Johlin FC. A percutaneous
biopsy technique for patients with suspected biliary or pancreatic cancer
without a radiographic mass. Abdom Imaging. 1997 May-Jun;22(3):307-10. [PubMed]
20.
20.Engelbrecht MR, Katz SS, van Gulik TM,
Laméris JS, van Delden OM. Imaging of perihilar cholangiocarcinoma. AJR Am J
Roentgenol. 2015 Apr;204(4):782-91. [PubMed]
21.
Shin DW, Moon SH, Kim JH. Diagnosis of
Cholangiocarcinoma. Diagnostics (Basel). 2023 Jan 08;13(2) [PMC free article]
[PubMed]
22.
Khan SA, Tavolari S, Brandi G.
Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019 May;39 Suppl
1:19-31. [PubMed]
23.
Banales JM, Cardinale V, Carpino G,
Marzioni M, Andersen JB, Invernizzi P, Lind GE, Folseraas T, Forbes SJ,
Fouassier L, Geier A, Calvisi DF, Mertens JC, Trauner M, Benedetti A, Maroni L,
Vaquero J, Macias RI, Raggi C, Perugorria MJ, Gaudio E, Boberg KM, Marin JJ,
Alvaro D. Expert consensus document: Cholangiocarcinoma: current knowledge and
future perspectives consensus statement from the European Network for the Study
of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016
May;13(5):261-80. [PubMed]
24.
Namsanor J, Kiatsopit N, Laha T, Andrews
RH, Petney TN, Sithithaworn P. Infection Dynamics of Opisthorchis viverriniMetacercariae
in Cyprinid Fishes from Two Endemic Areas in Thailand and Lao PDR. Am J Trop
Med Hyg. 2020 Jan;102(1):110-116. [PMC free article] [PubMed]
25.
Boonstra K, Weersma RK, van Erpecum KJ,
Rauws EA, Spanier BW, Poen AC, van Nieuwkerk KM, Drenth JP, Witteman BJ,
Tuynman HA, Naber AH, Kingma PJ, van Buuren HR, van Hoek B, Vleggaar FP, van
Geloven N, Beuers U, Ponsioen CY., EpiPSCPBC Study Group. Population-based
epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
Hepatology. 2013 Dec;58(6):2045-55. [PubMed]
26.
Huang D, Joo H, Song N, Cho S, Kim W, Shin
A. Association between gallstones and the risk of biliary tract cancer: a
systematic review and meta-analysis. Epidemiol Health. 2021;43:e2021011. [PMC
free article] [PubMed]
27.
Hoilat GJ, John S. StatPearls [Internet].
StatPearls Publishing; Treasure Island (FL): Aug 28, 2023. Choledochal Cyst.
[PubMed]
28.
Simo KA, Mckillop IH, Ahrens WA, Martinie
JB, Iannitti DA, Sindram D. Invasive biliary mucinous cystic neoplasm: a
review. HPB (Oxford). 2012 Nov;14(11):725-40. [PMC free article] [PubMed]
29.
Ellis RJ, Soares KC, Jarnagin WR.
Preoperative Management of Perihilar Cholangiocarcinoma. Cancers (Basel). 2022
Apr 24;14(9) [PMC free article] [PubMed]
30.
Orzan RI, Pojoga C, Agoston R, Seicean R,
Seicean A. Endoscopic Ultrasound in the Diagnosis of Extrahepatic
Cholangiocarcinoma: What Do We Know in 2023? Diagnostics (Basel). 2023 Mar
08;13(6) [PMC free article] [PubMed]
31.
Mocan T, Horhat A, Mois E, Graur F, Tefas
C, Craciun R, Nenu I, Spârchez M, Sparchez Z. Endoscopic or percutaneous
biliary drainage in hilar cholangiocarcinoma: When and how? World J
Gastrointest Oncol. 2021 Dec 15;13(12):2050-2063. [PMC free article] [PubMed]
32. van
der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ,
Gerritsen JJ, Greve JW, Gerhards MF, de Hingh IH, Klinkenbijl JH, Nio CY, de
Castro SM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ. Preoperative biliary
drainage for cancer of the head of the pancreas. N Engl J Med. 2010 Jan
14;362(2):129-37. [PubMed]